Stocknear Logo Search
ctrl K
/
Popular
  • KO Coca Cola Company
    Stock
  • TSLA Tesla Inc
    Stock
  • AMD Advanced Micro Devices
    Stock
  • SPY SPDR S&P 500 ETF Trust
    ETF
  • NVDA Nvidia
    Stock
Stocknear Logo
Home
Hedge Funds
News
Stock Analysis Pro
GILD 104.42

AI Score

0
XX

Unlock

(GILD)

AI Score

0
XX

Unlock

104.42
-0.12 (-0.11%)
At close: Apr 21, 2025, 3:59 PM
    Overview Financials Statistics Metrics Forecast Dark Pool Options Insider Dividends History Profile

Dividends

No dividend history available for .

GILD News

  • 2 months ago · Gilead says Trodelvy-Keytruda combo effective for aggressive breast cancer type - reuters.com
  • 2 months ago · Trodelvy® Plus Keytruda® Demonstrates a Statistically Significant and Clinically Meaningful Improvement in Progression Free Survival in Patients With Previously Untreated PD-L1+ Metastatic Triple-Negative Breast Cancer - businesswire.com
  • 2 months ago · Here's Why Gilead Sciences (GILD) is a Strong Value Stock - zacks.com
  • 2 months ago · What Analyst Projections for Key Metrics Reveal About Gilead (GILD) Q1 Earnings - zacks.com
  • 2 months ago · Should You Buy, Hold, or Sell GILD Stock Ahead of Q1 Earnings? - zacks.com
  • 2 months ago · Gilead Sciences (GILD) Reports Next Week: Wall Street Expects Earnings Growth - zacks.com
  • 2 months ago · Gilead vs Bristol Myers: Which Biotech Bigwig is a Better Bet Now? - zacks.com
  • 2 months ago · Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know - zacks.com
  • 2 months ago · Gilead Sciences to Release First Quarter 2025 Financial Results on Thursday, April 24, 2025 - businesswire.com
  • 2 months ago · Gilead Sciences (GILD) Increases Yet Falls Behind Market: What Investors Need to Know - zacks.com

Create Price Alert on GILD

Your price alert will notify you when the stock price is above 104.42.

Add to Watchlist